Antimicrobial resistance among Gram-positive pathogens in Saudi Arabia

Journal of Chemotherapy

Volumn 24, Issue 3, 2012, Pages 125-136

  Yezli, Saber ^a   Shibl, Atef M ^b   Livermore, David M ^c   Memish, Ziad A ^d  

^a Bioquell UK Ltd   (United Kingdom)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^d MINISTRY OF HEALTH   (Saudi Arabia)

Author keywords

MRSA; Multidrug resistant; Saudi Arabia; Staphylococcus aureus; Streptococcus pneumoniae; VRE

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAM; CEFOTAXIME; CEFPROZIL; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GATIFLOXACIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; MACROLIDE; NITROFURANTOIN; OFLOXACIN; OXYTETRACYCLINE; PENICILLIN G; RIFAMPICIN; ROXITHROMYCIN; SULFAMETHOXAZOLE; TETRACYCLINE; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; BACTERIURIA; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; GRAM POSITIVE BACTERIUM; HOSPITAL INFECTION; HOSPITAL PATIENT; MENINGITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PNEUMOCOCCAL INFECTION; PNEUMONIA; PULSED FIELD GEL ELECTROPHORESIS; REVIEW; SAUDI ARABIA; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; URINARY TRACT INFECTION; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; GRAM-POSITIVE BACTERIAL INFECTIONS; GRAM-POSITIVE COCCI; HUMANS; SAUDI ARABIA;

EID: 84866261875     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/1973947812Y.0000000010     Document Type: Review

References (128)

1. Memish ZA. The Hajj: communicable and non-communicable health hazards and current guidance for pilgrims. Euro Surveill. 2010;15:19671.
2. Noskin GA, Rubin RJ, Schentag JJ, Kluytmans J, Hedblom EC, Jacobson C, et al. National trends in Staphylococcus aureus infection rates: impact on economic burden and mortality over a 6-year period (1998-2003). Clin Infect Dis. 2007;45:1132-40.
3. Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339:520-32.
4. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med. 1991;91:72S-5S.
5. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374:893-902.
6. Bridy-Pappas AE, Margolis MB, Center KJ, Isaacman DJ. Streptococcus pneumoniae: description of the pathogen, disease epidemiology, treatment, and prevention. Pharmacotherapy. 2005;25:1193-212.
7. McKenzie H, Reid N, Dijkhuizen RS. Clinical and micro- biological epidemiology of Streptococcus pneumoniae bacteraemia. J Med Microbiol. 2000;49:361-6.
8. Asghar AH. Frequency and antimicrobial susceptibility patterns of bacterial pathogens isolated from septicemic patients in Makkah hospitals. Saudi Med J. 2006;27:361-7.
9. Saeed NK, Kambal AM, El-Khizzi NA. Antimicrobial-resistant bacteria in a general intensive care unit in Saudi Arabia. Saudi Med J. 2010;31:1341-9.
10. Al-Tawfiq JA, Abed MS. Prevalence and antimicrobial resistance of health care associated bloodstream infections at a general hospital in Saudi Arabia. Saudi Med J. 2009;30:1213-8.
11. Almuneef M, Memish ZA, Balkhy HH, Alalem H, Abutaleb A. Ventilator-associated pneumonia in a pediatric intensive care unit in Saudi Arabia: a 30-month prospective surveil-lance. Infect Control Hosp Epidemiol. 2004;25:753-8.
12. Al-Ghamdi S, Gedebou M, Bilal NE. Nosocomial infections and misuse of antibiotics in a provincial community hospital, Saudi Arabia. J Hosp Infect. 2002;50:115-21.
13. Abdel-Fattah MM. Surveillance of nosocomial infections at a Saudi Arabian military hospital for a one-year period. Ger Med Sci. 2005;3:Doc06.
14. Abussaud MJ. Prevalence of nosocomial infections in a Saudi Arabian teaching hospital. J Hosp Infect. 1991;17:235-8.
15. al-Orainey IO, al-Nasser MN, Saeed ES, Chowdhury MN. Nosocomial bacteraemia in a teaching hospital in Saudi Arabia. J Hosp Infect. 1989;14:201-7.
16. Bassetti M, Melica G, Cenderello G, Rosso R, Di BA, Bassetti D. Gram-positive bacterial resistance. A challenge for the next millennium. Panminerva Med. 2002;44:179-84.
17. Segreti J. Efficacy of current agents used in the treatment of Gram-positive infections and the consequences of resistance. Clin Microbiol Infect. 2005;11Suppl 3:29-35.
18. Twum-Danso K, Grant C, al-Suleiman SA, Abdel-Khader S, al-Awami MS, al-Breiki H, et al. Microbiology of post-operative wound infection: a prospective study of 1770 wounds. J Hosp Infect. 1992;21:29-37.
19. Asghar AH. Frequency and antibiotic susceptibility of gram-positive bacteria in Makkah hospitals. Ann Saudi Med. 2011;31:462-8.
20. Voss A, Doebbeling BN. The worldwide prevalence of methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents. 1995;5:101-6.
21. Maple PA, Hamilton-Miller JM, Brumfitt W. World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus. Lancet. 1989;1:537-40.
22. Woodford N, Livermore DM. Infections caused by Gram-positive bacteria: a review of the global challenge. J Infect. 2009;59Suppl 1:S4-16.
23. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol. 2005;26:166-74.
24. Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis. 2003;36:592-8.
25. Brumfitt W, Hamilton-Miller J. Methicillin-resistant Staphylococcus aureus. N Engl J Med. 1989;320:1188-96.
26. Struelens MJ, Monnet DL. Prevention of methicillin-resistant Staphylococcus aureus infection: is Europe winning the fight? Infect Control Hosp Epidemiol. 2010;31Suppl 1:S42-S44.
27. Geisel R, Schmitz FJ, Fluit AC, Labischinski H. Emergence, mechanism, and clinical implications of reduced glycopeptide susceptibility in Staphylococcus aureus. Eur J Clin Microbiol Infect Dis. 2001;20:685-97.
28. Fridkin SK, Hageman J, McDougal LK, Mohammed J, Jarvis WR, Perl TM, et al. Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clin Infect Dis. 2003;36:429-39.
29. Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med. 2003;348:1342-7.
30. Zaman R, Dibb WL. Methicillin resistant Staphylococcus aureus (MRSA) isolated in Saudi Arabia: epidemiology and antimicrobial resistance patterns. J Hosp Infect. 1994;26:297-300.
31. Shibl AM, Tawfik AF, Khan AM, Qadri SM, Imambaccus Y, Ramadan MA. Prevalence of methicillin-resistant staphylo-cocci in Riyadh, Saudi Arabia and their susceptibility to antimicrobial agents. J Antimicrob Chemother. 1994;33:1255-7.
32. Bukharie HA, Abdelhadi MS, Saeed IA, Rubaish AM, Larbi EB. Emergence of methicillin-resistant Staphylococcus aureus as a community pathogen. Diagn Microbiol Infect Dis. 2001;40:1-4.
33. Bukharie HA, Abdelhadi MS. The epidemiology of methicillin-resistant Staphylococcus aureus at a Saudi university hospital. Microb Drug Resist. 2001;7:413-6.
34. Akbar DH, Mushtaq MA, El-Tahawi AT, Bahnasy AA. Staphylococcus aureus bacteremia. Saudi Med J. 2000;21:171-4.
35. Madani TA. Epidemiology and clinical features of methicillin-resistant Staphylococcus aureus in the University Hospital, Jeddah, Saudi Arabia. Can J Infect Dis. 2002;13:245-50.
36. Madani TA, Al-Abdullah NA, Al-Sanousi AA, Ghabrah TM, Afandi SZ, Bajunid HA. Methicillin-resistant Staphylococcus aureus in two tertiary-care centers in Jeddah, Saudi Arabia. Infect Control Hosp Epidemiol. 2001;22:211-6.
37. Bilal NE, Gedebou M. Staphylococcus aureus as a paradigm of a persistent problem of bacterial multiple antibiotic resistance in Abha, Saudi Arabia. East Mediterr Health J. 2000;6:948-54.
38. Alghaithy AA, Bilal NE, Gedebou M, Weily AH. Nasal carriage and antibiotic resistance of Staphylococcus aureus isolates from hospital and non-hospital personnel in Abha, Saudi Arabia. Trans R Soc Trop Med Hyg. 2000;94:504-7.
39. Bilal NE, Gedebou M, Al-Ghamdi S. Endemic nosocomial infections and misuse of antibiotics in a maternity hospital in Saudi Arabia. APMIS. 2002;110:140-7.
40. Panhotra BR, Saxena AK, Al-Mulhim AS. Chloramphenicol susceptible methicillin resistant Staphylococcus aureus in eastern region of Saudi Arabia. Saudi Med J. 2005;26:1149-51.
41. Balkhy HH, Cunningham G, Chew FK, Francis C, Al Nakhli DJ, Almuneef MA, et al. Hospital-and community-acquired infections: a point prevalence and risk factors survey in a tertiary care center in Saudi Arabia. Int J Infect Dis. 2006;10:326-33.
42. Babay HA, Twum-Danso K, Kambal AM, Al-Otaibi FE. Bloodstream infections in pediatric patients. Saudi Med J. 2005;26:1555-61.
43. Baddour MM, AbuElKheir MM, Fatani AJ. Trends in antibiotic susceptibility patterns and epidemiology of MRSA isolates from several hospitals in Riyadh, Saudi Arabia. Ann Clin Microbiol Antimicrob. 2006;5:30.
44. Asghar AH, Momenah AM. Methicillin resistance among Staphylococcus aureus isolates from Saudi hospitals. Med Princ Pract. 2006;15:52-5.
45. Akhtar N, Alzahrani A, Obeid O, Dassal D. In vitro ciprofloxacin resistance patterns of gram-positive bacteria isolated from clinical specimens in a teaching hospital in Saudi Arabia. J Ayub Med Coll Abbottabad. 2009;21:54-6.
46. Al-Tawfiq JA. Incidence and epidemiology of methicillin-resistant Staphylococcus aureus infection in a Saudi Arabian Hospital, 1999-2003. Infect Control Hosp Epidemiol. 2006;27:1137-9.
47. Fluit AC, Wielders CL, Verhoef J, Schmitz FJ. Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study. J Clin Microbiol. 2001;39:3727-32.
48. National Nosocomial Infections Surveillance. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004;32:470-85.
49. Moussa I, Shibl AM. Molecular characterization of methi-cillin-resistant Staphylococcus aureus recovered from out-patient clinics in Riyadh, Saudi Arabia. Saudi Med J. 2009;30:611-7.
50. Bukharie HA. Increasing threat of community-acquired methicillin-resistant Staphylococcus aureus. Am J Med Sci. 2010;340:378-81.
51. Bukhari EE, Al-Otaibi FE. Severe community-acquired infection caused by methicillin-resistant Staphylococcus aureus in Saudi Arabian children. Saudi Med J. 2009;30:1595-600. 71
52. Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with 72 no identified predisposing risk. JAMA. 1998;279:593-8.
53. Maguire GP, Arthur AD, Boustead PJ, Dwyer B, Currie BJ. Clinical experience and outcomes of community-acquired and 73 nosocomial methicillin-resistant Staphylococcus aureus in a northern Australian hospital. J Hosp Infect. 1998;38:273-81.
54. Balkhy HH, Memish ZA, Almuneef MA, Cunningham GC, 74 study in South American hospitals. J Clin Microbiol. 2010;48:1562-9.
55. Austin TW, Austin MA, McAlear DE, Coleman BT, Osoba AO, Thaqafi AO, et al. MRSA prevalence in a teaching hospital in Western Saudi Arabia. Saudi Med J. 2003;24:1313-6.
56. Panhotra BR, Saxena AK, Al Mulhim AS. Prevalence of methicillin-resistant and methicillin-sensitive Staphylococcus aureus nasal colonization among patients at the time of admission to the hospital. Ann Saudi Med. 2005;25:304-8.
57. Islam SI, Moore C. Prevalence of methicillin-resistant Staphyloccocus aureus and associated risk factors on admis-sion to a specialist care eye hospital. Ann Saudi Med. 2002;22:153-7.
58. Ahmad S. The prevalence of Staphylococcus aureus colonization among healthcare workers at a specialist hospital in Saudi Arabia. JCDR. 2010;4:2438-41.
59. van BA, Vandenbergh M, Kessie G, Qadri SM, Lee G, van den Braak N, et al. Genetic homogeneity among methicillin-resistant Staphylococcus aureus strains from Saudi Arabia. Microb Drug Resist. 1997;3:365-9.
60. Cirlan M, Saad M, Coman G, Bilal NE, Elbashier AM, Kreft D, et al. International spread of major clones of methicillin resistant Staphylococcus aureus: nosocomial endemicity of multi locus sequence type 239 in Saudi Arabia and Romania. Infect Genet Evol. 2005;5:335-9.
61. Chongtrakool P, Ito T, Ma XX, Kondo Y, Trakulsomboon S, Tiensasitorn C, et al. Staphylococcal cassette chromosome mec (SCCmec) typing of methicillin-resistant Staphylococcus aureus strains isolated in 11 Asian countries: a proposal for a new nomenclature for SCCmec elements. Antimicrob Agents Chemother. 2006;50:1001-12.
62. Baddour MM, AbuElKheir MM, Fatani AJ, Bohol MF, Al-Ahdal MN. Molecular epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) isolates from major hospitals in Riyadh, Saudi Arabia. Can J Microbiol. 2007;53:931-6.
63. Biedenbach DJ, Moet GJ, Jones RN. Occurrence and antimicrobial resistance pattern comparisons among blood-stream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002). Diagn Microbiol Infect Dis. 2004;50:59-69.
64. Shepard BD, Gilmore MS. Antibiotic-resistant enterococci: the mechanisms and dynamics of drug introduction and resistance. Microbes Infect. 2002;4:215-24.
65. Deshpande LM, Fritsche TR, Moet GJ, Biedenbach DJ, Jones RN. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveil- lance program. Diagn Microbiol Infect Dis. 2007;58:163-70.
66. Bell J, Turnidge J, Coombs G, O'Brien F. Emergence and epidemiology of vancomycin-resistant enterococci in Australia. Commun Dis Intell. 1998;22:249-52.
67. Khudaier BY, Tewari R, Shafiani S, Sharma M, Emmanuel R, Sharma M, et al. Epidemiology and molecular characteriza-tion of vancomycin resistant Enterococci isolates in India. Scand J Infect Dis. 2007;39:662-70.
68. Kirdar S, Sener AG, Arslan U, Yurtsever SG. Molecular epidemiology of vancomycin-resistant Enterococcus faecium strains isolated from haematological malignancy patients in a research hospital in Turkey. J Med Microbiol. 2010;59:660-4.
69. Song JY, Hwang IS, Eom JS, Cheong HJ, Bae WK, Park YH, et al. Prevalence and molecular epidemiology of vancomycin-resistant enterococci (VRE) strains isolated from animals and humans in Korea. Korean J Intern Med. 2005;20:55-62.
70. Panesso D, Reyes J, Rincon S, Diaz L, Galloway-Pena J, Zurita J, et al. Molecular epidemiology of vancomycin-resistant Enterococcus faecium: a prospective, multicenter bacteremia in a teaching hospital in the Central region of Saudi Arabia. Saudi Med J. 2004;25:21-5.
71. Nashmi A, Memish ZA. Infective endocarditis at a tertiary care centre in Saudi Arabia: review of 47 cases over 10 years. East Mediterr Health J. 2007;13:64-71.
72. Al-Tawfiq JA, Sufi I. Infective endocarditis at a hospital in Saudi Arabia: epidemiology, bacterial pathogens and outcome. Ann Saudi Med. 2009;29:433-6.
73. Ahmad S, Ahmad F. Urinary tract infection at a specialist hospital in Saudi Arabia. Bangladesh Med Res Counc Bull. 1995;21:95-8.
74. Al-Otaibi FE, Kambal AM, Baabbad RA. Enterococcal bacteremia in a teaching hospital in the Central region of Saudi Arabia. Saudi Med J. 2004;25:21-5.
75. Kholeif MA, Kinsara AJ, George BO, Mowallad AW, Bugis FA, Osoba AO. Enterococcus faecalis endocarditis. Saudi Med J. 2002;23:1120-3.
76. al-Mugeiren MM, Qadri SM. Bacteriologic profile and drug resistance in pediatric patients with symptomatic bacteriuria. Clin Ther. 1996;18:295-300.
77. Abd-Elalim Eltahawy AT, Fouad Khalaf RM. Comparative in-vitro activity of fourteen antibiotics against clinical isolates of enterococci. J Chemother. 1990;2:351-4.
78. Al-Ballaa SR, Qadri SM, Al-Ballaa SR, Kambal AM, Saldin H, Al-Qatary K. High level resistance to aminoglycosides in enterococci from Riyadh. Ann Saudi Med. 1994;14:290-3.
79. Al-Tawfiq JA, Anani AA. Antimicrobial susceptibility pattern of bacterial pathogens causing urinary tract infections in a Saudi Arabian hospital. Chemotherapy. 2009;55:127-31.
80. Qadri SM, Ellis ME, Al-Rabiah F, Ernst P, Ingemansson S. High-level, multiresistant enterococci associated with systemic disease: A report of two cases. Ann Saudi Med. 1996;16:682-5.
81. Qadri SH, Qunibi WY, Al-Ballaa SR, Kadhi Y, Burdette JM. Vancomycin resistant Enterococcus: A case report and review of the literature. Ann Saudi Med. 1993;13:289-93.
82. Osoba AO, Jeha MT, Bakheshwain S, Al-Anazi K, Bartlett F. Septicemia due to vancomycin resistant Enterococcus: A case report. Saudi Med J. 1995;16:67-9.
83. Khan MA, van der Wal M, Farrell DJ, Cossins L, van BA, Alaidan A, et al. Analysis of VanA vancomycin-resistant Enterococcus faecium isolates from Saudi Arabian hospitals reveals the presence of clonal cluster 17 and two new Tn1546 lineage types. J Antimicrob Chemother. 2008;62:279-83.
84. Qadri SM, Postle AG. Vancomycin-resistant enterococci (VRE) as normal flora of the intestine in patients at a tertiary care hospital. Ann Saudi Med. 1996;16:625-8.
85. Low DE, Keller N, Barth A, Jones RN. Clinical prevalence, antimicrobial susceptibility, and geographic resistance pat-terns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis. 2001;32Suppl 2: S133-S145.
86. Amyes SG. Enterococci and streptococci. Int J Antimicrob Agents. 2007;29Suppl 3: S43-S52.
87. Reinert RR. The antimicrobial resistance profile of Streptococcus pneumoniae. Clin Microbiol Infect. 2009;15Suppl 3: 7-11.
88. Lynch JP, III, Zhanel GG. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines. Curr Opin Pulm Med. 2010;16:217-25.
89. Memish ZA, Balkhy HH, Shibl AM, Barrozo CP, Gray GC. Streptococcus pneumoniae in Saudi Arabia: antibiotic resis-tance and serotypes of recent clinical isolates. Int J Antimicrob Agents. 2004;23:32-8.
90. Memish ZA, Osoba AO, Shibl AM, Mokaddas E, Venkatesh S, Rotimi VO. Emergence and trends of penicillin non-susceptible Streptococcus pneumoniae in Saudi Arabia and Kuwait -perspective and outstanding issues. J Chemother. 2007;19:471-81.
91. Lynch JP, III, Zhanel GG. Escalation of antimicrobial resistance among Streptococcus pneumoniae: implications for therapy. Semin Respir Crit Care Med. 2005;26:575-616.
92. Fuller JD, Low DE. A review of Streptococcus pneumonia infection treatment failures associated with fluoroquinolone resistance. Clin Infect Dis. 2005;41:118-21.
93. Daneman N, Low DE, McGeer A, Green KA, Fisman DN. At the threshold: defining clinically meaningful resistance thresholds for antibiotic choice in community-acquired pneumonia. Clin Infect Dis. 2008;46:1131-8.
94. Jacobs MR, Koornhof HJ, Robins-Browne RM, Stevenson CM, Vermaak ZA, Freiman I, et al. Emergence of multiply resistant pneumococci. N Engl J Med. 1978;299:735-40.
95. Marimon JM, Alonso M, Rolo D, Ardanuy C, Linares J, Perez-Trallero E. Molecular characterization of Streptococcus pneumoniae invasive serotype 19A isolates from adults in two Spanish regions (1994-2009). Eur J Clin Microbiol Infect Dis 2011.
96. Jenkins SG, Brown SD, Farrell DJ. Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4. Ann Clin Microbiol Antimicrob. 2008;7:1.
97. Lynch JP, III, Zhanel GG. Streptococcus pneumoniae: does antimicrobial resistance matter? Semin Respir Crit Care Med. 2009;30:210-38.
98. Mokaddas EM, Rotimi VO, Albert MJ. Implications of Streptococcus pneumoniae penicillin resistance and serotype distribution in Kuwait for disease treatment and prevention. Clin Vaccine Immunol. 2008;15:203-7.
99. Hansman D, Bullen MM. A resistant pneumococcus. Lancet. 1967;ii:2164-5.
100. Chowdhury MN. A penicillin-resistant Streptococcus pneumoniae; case report. Trop Geogr Med. 1983;35:309-11.
101. Mahgoub ES, Hussein SS. Streptococcus pneumoniae serotypes and their minimal inhibitory concentration to penicillin in Riyadh. Saudi Med J. 1986;7:149-54.
102. El-Mouzan MI, Twan-Danso K, Al-Awamy BH, Niazi GA, Altorki MT. Pneumococcal infections in eastern Saudi Arabia: serotypes and antibiotic sensitivity patterns. Trop Geogr Med. 1988;40:213-7.
103. Shibl AM, Hussein SS. Surveillance of Streptococcus pneumo-niae serotypes in Riyadh and their susceptibility to penicillin and other commonly prescribed antibiotics. J Antimicrob Chemother. 1992;29:149-57.
104. Qadri SM, Kroschinsky R. Prevalence of pneumococci with increased resistance to penicillin in Saudi Arabia. Ann Trop Med Parasitol. 1991;85:259-62.
105. Qadri SM, Lee GC, Ueno Y, Burdette JM. Incidence of bacterial respiratory pathogens and their susceptibility to common antibacterial agents. J Natl Med Assoc. 1993;85:388-90.
106. Bannatyne RM, Memish ZA, Jackson MC. Correlation between serotype and in-vitro antibiotic susceptibility of pneumococci isolated in Saudi Arabia. J Antimicrob Chemother. 1999;43:161-2.
107. Felmingham D, Gruneberg RN. The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respira-tory tract infections. J Antimicrob Chemother. 2000;45:191-203.
108. Al-Aqeeli AA, Guy ML, Al-Jumaah SA. Streptococcus pneumoniae resistance to penicillin and ceftriaxone in a tertiary care center in Saudi Arabia. Saudi Med J. 2002;23:400-4.
109. Fouda SI, Kadry AA, Shibl AM. Beta-lactam and macrolide resistance and serotype distribution among Streptococcus pneumoniae isolates from Saudi Arabia. J Chemother. 2004;16:517-23.
110. Twum-Danso K, Al-Mazrou AM, Kambal AM, Al-Zamil FA. Penicillin resistance in serogroups/serotypes of Streptococcus pneumoniae causing invasive infections in Central Saudi Arabia. Saudi Med J. 2003;24:1210-3.
111. Rotimi VO, Fetuh J, Barbor PR. Prevalence of penicillin-resistant Streptococcus pneumoniae in a Saudi Arabian hospital. Eur J Clin Microbiol Infect Dis. 1995;14:149-51.
112. Eltahawy AT. Antimicrobial resistance of Streptococcus pneumoniae at a university hospital in Saudi Arabia. J Chemother. 2001;13:148-53.
113. Al-Tawfiq JA. Pattern of antibiotic resistance of Streptococcus pneumoniae in a hospital in the Eastern Province of Saudi Arabia. J Chemother. 2004;16:259-63.
114. Al-Tawfiq JA. Antibiotic resistance of pediatric isolates of Streptococcus pneumoniae in a Saudi Arabian hospital from 1999 to 2004. Med Sci Monit. 2006;12:CR471-CR475.
115. Rahman EA, Dixon RA. Resistance of Streptococcus pneumoniae from Saudi Arabia. Int J Antimicrob Agents. 1999;13:61-2.
116. Shibl AM. Patterns of macrolide resistance determinants among S. pyogenes and S. pneumoniae isolates in Saudi Arabia. J Int Med Res. 2005;33:349-55.
117. Shibl AM, Al Rasheed AM, Elbashier AM, Osoba AO. Penicillin-resistant and -intermediate Streptococcus pneumo-niae in Saudi Arabia. J Chemother. 2000;12:134-7.
118. Shibl AM. Distribution of serotypes and antibiotic resistance of invasive pneumococcal disease isolates among children aged 5 years and under in Saudi Arabia (2000-2004). Clin Microbiol Infect. 2008;14:876-9.
119. Chowdhury MN, Khaliq MR, Kambal AM. Penicillin-resistant Streptococcus pneumoniae in Riyadh, Saudi Arabia. Int J Antimicrob Agents. 1995;6:37-41.
120. Conly J, Johnston B. Macrolide resistance in Streptococcus pneumoniae: Fallacy or fact? Can J Infect Dis. 2002;13:13-6.
121. Mingoia M, Vecchi M, Cochetti I, Tili E, Vitali LA, Manzin A, et al. Composite structure of Streptococcus pneumoniae containing the erythromycin efflux resistance gene mefI and the chloramphenicol resistance gene catQ. Antimicrob Agents Chemother. 2007;51:3983-7.
122. Montanari MP, Cochetti I, Mingoia M, Varaldo PE. Phenotypic and molecular characterization of tetracycline-and erythromycin-resistant strains of Streptococcus pneumo-niae. Antimicrob Agents Chemother. 2003;47:2236-41.
123. Balkhy HH, Memish ZA, Shibl A, Elbashier A, Osoba A. In vitro activity of quinolones against S. pneumoniae, H. influenzae and M. catarrhalis in Saudi Arabia. East Mediterr Health J. 2005;11:36-44.
124. Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, et al. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med. 1999;340:493-501.
125. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother. 1997;40:135-6.
126. Tenover FC. Implications of vancomycin-resistant Staphylococcus aureus. J Hosp Infect. 1999;43S3-S7.
127. Al-Obeid S, Haddad Q, Cherkaoui A, Schrenzel J, Francois P. First detection of an invasive Staphylococcus aureus strain (D958) with reduced susceptibility to glycopeptides in Saudi Arabia. J Clin Microbiol. 2010;48:2199-204.
128. Bilal NE, Gedebou M. Staphylococcus aureus as a paradigm of a persistent problem of bacterial multiple antibiotic resistance in Abha, Saudi Arabia. East Mediterr Health J. 2000;6:948-54.